Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D
Basel Institute for Immunology, Switzerland.
Eur J Immunol. 1992 Oct;22(10):2573-8. doi: 10.1002/eji.1830221016.
To identify the ligand for the B cell-associated antigen CD40, we constructed a chimeric immunoglobulin molecule where the extracellular portion of the CD40 protein replaced the normal immunoglobulin variable region. No binding was detected on resting peripheral blood T cells. However, following T cell activation with phorbol esters and ionomycin, the chimeric protein bound specifically to activated human T cells and precipitated a 35-kDa protein from such cells. The induction of the CD40 ligand was detectable on the cell surface after 1 h, with maximal expression after 8 h of stimulation. The T cells expressing CD40 ligand were predominantly CD4 positive, although a proportion of CD8-positive cells also expressed the protein. There was no particular correlation with CD45 phenotype. Finally, we found that soluble CD40 inhibited T-dependent B cell proliferation. The results are discussed in the context of cognate interactions between B and T cells.
为了鉴定B细胞相关抗原CD40的配体,我们构建了一种嵌合免疫球蛋白分子,其中CD40蛋白的细胞外部分取代了正常免疫球蛋白可变区。在静息外周血T细胞上未检测到结合。然而,在用佛波酯和离子霉素激活T细胞后,嵌合蛋白特异性结合活化的人T细胞,并从此类细胞中沉淀出一种35 kDa的蛋白。CD40配体在刺激1小时后在细胞表面可检测到,刺激8小时后表达达到最大值。表达CD40配体的T细胞主要为CD4阳性,尽管一部分CD8阳性细胞也表达该蛋白。与CD45表型没有特别的相关性。最后,我们发现可溶性CD40抑制T细胞依赖的B细胞增殖。将在B细胞和T细胞之间同源相互作用的背景下讨论这些结果。